Why does the active metabolite of mycophenolate mofetil hydrochloride (CellCept) have stronger cytostatic effects on lymphocytes than on other cells?

CellCept’s active metabolite MPA inhibits IMPDH and thus de novo guanosine nucleotide synthesis, on which T- and B-lymphocytes critically depend for proliferation, whereas other cells can use salvage pathways.